#+TITLE: Laboratory Methods for Quantitative Amino Acid Analysis in Biological Matrices
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today
:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
#+BEAMER_THEME: Frankfurt [height=20pt]
#+BEAMER_COLOR_THEME: whale
#+BEAMER_FRAME_LEVEL: 2
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:nil
#+PROPERTY: header-args:R :session *R*
#+PROPERTY: header-args :cache no
#+PROPERTY: header-args :tangle yes
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{What is an Automated and Reproducible Report?}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario | The University of Ottawa}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=white,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
:END:

#+BEGIN_LaTeX
%\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}~%
%    \includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}%
%}

\vspace{220pt}}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}

\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=5em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]

#+END_LaTeX

* Introduction
** Amino Acids: A Very Short Introduction
- Amino acids are mono or dicarboxylic acids with one or more amino groups.
  - Zwitterion at ph 7.45

- Proteinogenic amino acids (22)
  - 21 amino acids naturally incorportated into polypeptides in humans
  - 20 genetically encoded
  - selenocysteine

- Non-proteinogenic
  - post-translational modification
    - hydroxylation of proline \to hydroxyproline
  - Not found in proteins
    - gamma-aminobutryic acid
    - ornithine, citrulline

- 76 amino acids of biological interest in humans

** COMMENT Indications for Measurement of Amino Acids
1. Lethargy, coma, seizures or vomiting in a neonate
2. Hyperammonaemia
3. Ketosis
4. Metabolic acidosis or lactic acidaemia
5. Alkalosis
6. Metabolic decompensation
7. Unexplained developmental delay or developmental regression
8. Polyuria, polydipsia and dehydration
9. Unexplained liver dysfunction
10. Unexplained neurological symptoms
11. Abnormal amino acid results on newborn screening programme
12. Previous sibling with similar clinical presentation
13. Clinical presentation specific to an amino acid disorder
14. Monitoring treatment and diet.

** Indications for Measurement of Amino Acids 
- Diagnosis of inborn errors of amino acid metabolism and transport
- Diet monitoring in patients with known IEM
- Nutritional assessment of patients with non-metabolic conditions [e.g. short bowel syndrome] 

** Quantitative Amino Acid Analysis
***                                                                 :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:

[[./figures/Moore_Stein.png]]

***                                                                 :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:

- Stanford Moore (left) and William Stein (right) about 1965 in front
  of the original amino acid analyzer.
- Ion-exchange chromatography with post-column ninhydrin detection

** Metbionet Guidelines for Amino Acid Analysis.

*** Plasma Profile for Diagnosis of Amino Acid Disorders

****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.3
:END:
- Alanine
- Alloisoleucine
- Arginine
- Argininosuccinic acid
- Cystine
- Citrulline
- Glutamic acid


****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.3
:END:
- Glutamine
- Glycine
- Histidine
- Homocysteine*
- Isoleucine
- Leucine
- Lysine
- Methionine
****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.3
:END:

- Ornithine
- Phenylalanine
- Proline
- Serine
- Sulphocysteine**
- Taurine
- Threonine
- Tyrosine
- Valine

***                                                       :B_ignoreheading:
:PROPERTIES:
:BEAMER_env: ignoreheading
:END:
- *Plasma total homocysteine is not detected by routine methods, plasma free homocystine analysis has poor clinical sensitivity.
- **Sulphocysteine may not be detectable in plasma using routine methods
** Plasma
- Patient prep
  - Fasting (overnight preferred, 4 hours minimum). Infants and children should be
    drawn just before next feeding (2-3 hours without TPN if possible).
- Sample
  - LiHeparin venous plasma
  - Prompt separation and deproteinisation is essential for accurate measurement of (free) sulphur containing amino acids.
  - Protein binding: cystine and homocystine
  - release of arginase from RBCs
  - store at -20\degree{}C to limit glutamine decomposition

** Plasma - Pre-analytical

- Serum should not be used because there may be deamination (asparagine to
  aspartic acid and glutamine to glutamic acid), loss of sulphur
  containing amino acids and release of oligopeptides.
- EDTA plasma is recommended in some labs as the specimen of
  choice. The older literature reports ninhydrin positive artefacts in
  EDTA plasma but modern tubes do not seem to have this problem.
- Haemolysis will cause increases in serine, glycine, taurine,
  phosphoethanolamine, aspartic acid, glutamic acid, ornithine and
  decreased arginine.
- Delayed separation or leucocyte and platelet contamination will
  cause increased serine, glycine, taurine, phosphoethanolamine,
  ornithine, glutamic acid and decreased arginine, homocystine,
  cystine.
- Phenylalanine and tyrosine increase if specimen separation is
  delayed 
- Amino acids are more stable in frozen deproteinised plasma than
  in frozen native plasma.
- Capillary blood may be used with careful cleaning of the skin prior
  to specimen collection provided the blood is flowing freely.
- Free tryptophan may be lost when using sulphosalicylic acid as
  deproteinising agent.
  - trichloroacetic acid is the deproteinising agent of choice for
    this amino acid.
- Sodium metabisulphite, found in some intravenous preparations as a
  preservative, can cause the conversion of cystine to sulphocysteine.

** Urine
- Urine
  - 24 hour or random urine
  - preservative free bottle
  - Specimen quality is checked by testing for nitrite and pH.
    - Specimen deterioration causes:
      - \downarrow serine
      - \uparrow \downarrow alanine
      - increased glycine
      - decarboxylation of glutamic acid \to \gamma{}-aminobutyric acid
      - breakdown of phosphoethanolamine \to ethanolamine and phosphate
      - breakdown of cystathionine \to homocystine
      - hydrolysis of peptides causing \uparrow proline
  - Fecal contamination causes increased proline, glutamic acid, branched chain amino acids but not hydroxyproline.
  - Faecal bacteria can produce \gamma{}-aminobutyric acid from glutamic acid and b-alanine from aspartic acid
  - reported in \micro{}mol/g creatinine
  - Aminoaciduria due to overflow and amino acid transport defects.

** Cerebral Spinal Fluid
  - free of blood contamination
  - which tube is used?
  - investigation of neurological disorders and essential for the
    diagnosis of non-ketotic hyperglycinaemia.
  - CSF/Plasma ratio of amino acids is more informative than an isolated CSF sample.
    - A paired plasma sample should be obtained within two hours.
** Dried Blood Spot
  - Collected from free flowing blood spotted onto filter paper
  - Newborn Screening
  - Monitoring Therapy/Diet
  - Each DBS is assume to contain 3.2 \micro{}L of blood
  - The quantity of blood present in the paper varies by
    - hematocrit
    - degree of saturation
    - the cotton fiber paper
    - the environment  when applying blood (humidity and temperature).
  - Because of these numerous factors, a dried blood spot is a highly
    imprecise specimen compared with liquids such as urine, blood, and plasma.

  - Amniotic Fluid
    - prenatal diagnosis of IMD

    - Still used?

** COMMENT Sample prep
- Hydrophillic amino acids require deprotonization with acetonitrile or alcohol
- Deproteination to release cysteine, homocysteine and tryptophan.

** ERNDIM Plasma Amino Acids Survey

#+ATTR_LATEX: :height 0.9\textheight
[[./figures/erndim.png]]

* Amino Acid Analyser
** Amino Acid Analyser Schematic

#+BEGIN_LaTeX
\begin{center}
\begin{tikzpicture}[node distance=9em]
% nodes
\node(column)[msw, right of=extraction]{Chromatography};
\node(derivatization)[msw, right of=column]{Ninhyrin Derivatization};
\node(detector)[ms, right of=derivatization]{UV Detector};
% arrows
\draw[arrow](column) -- (derivatization);
\draw[arrow](derivatization) -- (detector);
\end{tikzpicture}

\vspace{2em}

\schemedebug{false}
\schemestart
\chemfig[][scale=.33]{*6(=*5(-(=O)-(-[6]OH)(-[8]OH)-(=O)-)-=-=-)}
\+
\chemfig[][scale=.5]{{\color{red}R}-[::-60](<[::-60]NH_3^+)-[::60](=[::60]O)-[::-60]OH}
\arrow{-U>[][{\tiny \ce{2H2O}}]}
\chemfig[][scale=.33]{*6(=*5(-(=O)-(=N-[::-60](-[::-60]{\color{red}R})-[::60](=[::60]O)-[::-60]OH)-(=O)-)-=-=-)}
\arrow{->[][]}
\chemfig[][scale=.33]{*6(=*5(-(=O)-(-N=*5(-(=O)-(*6(-=-=-))--(=O)-))-(=O)-)-=-=-)}
\schemestop

\schemedebug{false}
\schemestart
\chemfig[][scale=.33]{*6(=*5(-(=O)-(-[6]OH)(-[8]OH)-(=O)-)-=-=-)}
\+
\chemfig[][scale=.33]{H-*5(N----(-COOH)-)}
\arrow{->[][]}
\chemfig[][scale=.33]{*6(=*5(-(=O)-(-*5(N-----))-(=O)-)-=-=-)}
\schemestop
\end{center}
#+END_LaTeX

** Amino Acid Analyser
- Cation-exchange chromatography using a lithium buffer system
  followed by post-column derivatization with ninhydrin




***                                                                 :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:

- Samples are de-proteinized with sulfosalicylic acid prior to
  injection
- Utilizes a lithium-based cation-exchange column
- Eluting amino acids undergo post column reaction with ninhydrin
- Optical detection in the visible spectrum
  - amino acids: 570nm
  - imino acids 440 nm

***                                                                 :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:

[[./figures/212.jpg]]

** Amino Acid Analyser 

[[./figures/aaachrom.png]]

** Pros and Cons of Amino Acid Analysers

*** Pros
- Standardized and established technology
- Interpretive experience
*** Cons
- Long run time (90 – 150 minutes)
- Lack of analyte specificity (identification by retention time)
  - antibiotics (ampicillin, amoxicillin, and gentamicin), acetaminophen
- Co-eluting substances cannot be separated and distinguished on a standard IEC chromatogram
  - Homocitrulline co-elutes with methionine 
  - ASA co-elutes with leucine
  - Alloisoleucine co-elutes with cystathionine
  - Tryptophan co-elutes with histidine

* FIA-MS/MS

** FIA-MS/MS sample 

- Amino acids in the DBS eluate are esterified as butyl esters with butanol-hydrogen chloride.

#+BEGIN_LaTeX
\centering
\schemedebug{false}
\schemestart
\chemname{\chemfig[][scale=.33]{{\color{red}R}-[::-60](<[::-60]NH_3^+)-[::60](=[::60]O)-[::-60]OH}}{\tiny \textalpha{}-amino acid}
\+
\chemname{\chemfig[][scale=.33]{HO-[::30]-[::-60]-[::60]-[::-60]}}{\tiny n-butanol}
\arrow{-U>[][{\tiny \ce{H2O}}]}
\chemname{\chemfig[][scale=.33]{{\color{red}R}-[::-60](<[::-60]NH_3^+)-[::60](=[::60]O)-[::-60]O-[::60]-[::-60]-[::60]-[::-60]}}{\tiny AA butyl ester}
\schemestop
#+END_LaTeX


- Solvent delivery is via HPLC with no chromatography, called flow injection analysis.
- 10 \micro{}L of sample extract is injected into a flowing stream operating at ~ 0.15 ml/min.

- Typical injection rates between samples are 2 min, giving a potential 400-
  to 600-sample capacity per instrument per day.
  - volume is typically 200-400 specimens per instrument per day
  - maintenance issues, repeat specimen analysis.
    
** FIA-MS/MS schematic
#+BEGIN_LaTeX
\begin{center}
\begin{tikzpicture}[node distance=7em]
% nodes
\node(ms1)[ms]{MS1: Mass Filter};
\node(cc)[ms, right of=ms1]{Collision cell};
\node(ms2)[ms, right of=cc]{MS2: Mass Filter};
\node(ion)[ms, below of=ms1,yshift=3em]{Ionization};
\node(lc)[msw, below of=ion,yshift=3em]{Injection};
\node(detector)[ms, below of=ms2, yshift=3em]{Detector};
% arrows
\draw[arrow](lc) -- (ion);
\draw[arrow](ion) -- (ms1);
\draw[arrow](ms1) -- (cc);
\draw[arrow](cc) -- (ms2);
\draw[arrow](ms2) -- (detector);
\end{tikzpicture}
\end{center}
#+END_LaTeX


** FIA-MS/MS transitions

- Electrospray ionization in positive mode
- \alpha{}-amino acids fragment to produce the neutral butyl formate molecule (102 Da). 
- A neutral loss scan is used to identify parent molecules with a NL of 102 Da.
- MRM is used to detected amino acids with basic functional groups
  - arginine, ornithine and citrulline

#+BEGIN_LaTeX
\centering
\schemedebug{false}
\schemestart
\chemname{\chemfig[][scale=.33]{{\color{red}R}-[::-60](<[::-60]NH_3^+)-[::60](=[::60]O)-[::-60]O-[::60]-[::-60]-[::60]-[::-60]}}{\tiny AA butyl ester}
\arrow{->[{\tiny fragmentation}]}
\chemname{\chemfig[][scale=.33]{{\color{red}R}-[::60]=NH_2^{+}}}{\tiny fragment}
\+
\chemname{\chemfig[][scale=.33]{H-[::60](=[::60]O)-[::-60]O-[::60]-[::-60]-[::60]-[::-60]}}{\tiny butyl formate (102 Da)}
\schemestop
#+END_LaTeX

** FIA-MS/MS  MRM

- Citrulline contains a labile amino group that fragments together with butyl formate.
- CID results in net neutral fragmentation of butyl formate (102 Da) plus \ce{NH3} (17 Da)
- [[https://en.wikipedia.org/wiki/Selected_reaction_monitoring][SRM]] Citrulline-Bu 232.15 Da \to 113 Da , loss of 119 Da  

#+BEGIN_LaTeX
\centering
\schemedebug{false}
\schemestart
\chemname{\chemfig[][scale=.33]{H_2N-[::30,,2,](=[::60]O)-[::-60]NH-[::60]-[::-60]-[::60]-[::-60](<[::-60]NH_3^+)-[::60](=[::60]O)-[::-60]OH}}{\tiny citrulline 175 Da}
\+
\chemname{\chemfig[][scale=.33]{HO-[::30]-[::-60]-[::60]-[::-60]}}{\tiny n-butanol 74 Da}
\arrow{-U>[][{\tiny \ce{H2O}}]}
\chemname{\chemfig[][scale=.33]{H_2N-[::30,,2,](=[::60]O)-[::-60]NH-[::60]-[::-60]-[::60]-[::-60](<[::-60]NH_3^+)-[::60](=[::60]O)-[::-60]O-[::60]-[::-60]-[::60]-[::-60]}}{\tiny 232 Da}
\schemestop
#+END_LaTeX



#+BEGIN_LaTeX
\centering
\schemedebug{false}
\schemestart
\chemname{\chemfig[][scale=.33]{H_2N-[::60]-[::-60]-[::60]-[::-60]-[::60]N=O=C}}{\tiny 113 Da}
\+
\chemname{\chemfig[][scale=.33]{H-[::60](=[::60]O)-[::-60]O-[::60]-[::-60]-[::60]-[::-60]}}{\tiny 102 Da}
\+
\chemname{\chemfig[][scale=.43]{NH_3}}{\tiny 17 Da}
\schemestop
#+END_LaTeX

- Its name is derived from citrullus, the Latin word for watermelon, from which it was first isolated in 1914 by Koga and Odake. 


** FIA-MS/MS Amino Acid Scan
*** Quantified Amino Acids
****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:
- Glycine
- Alanine
- Valine
- Leucine
- Methionine
- Phenylalanine
****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.5
:END:
- Tyrosine
- Ornithine
- Citruline
- Arginine
- \color{blue}Succinylacetone


** Pros and Cons of FIA-MS/MS using DBS
- As compared to AAA and LC-MS/MS 
*** Pros
- ~ 2 min analysis time
- Analyte specificity
- Acylcarnitines quantified simultaneously

*** Cons
- Variability in DBS sample as described above
- Iso-baric compounds
  - leucine, Isoleucine, Alloisoleucine
- Fewer AA quantified
  - homocystine (free)
  - glutamine

* LC-MS/MS
** LC-MS/MS schematic
#+BEGIN_LaTeX
\begin{center}
\begin{tikzpicture}[node distance=7em]
% nodes
\node(ms1)[ms]{MS1: Mass Filter};
\node(cc)[ms, right of=ms1]{Collision cell};
\node(ms2)[ms, right of=cc]{MS2: Mass Filter};
\node(ion)[ms, below of=ms1,yshift=3em]{Ionization};
\node(lc)[msw, below of=ion,yshift=3em]{Chromatography};
\node(detector)[ms, below of=ms2, yshift=3em]{Detector};
% arrows
\draw[arrow](lc) -- (ion);
\draw[arrow](ion) -- (ms1);
\draw[arrow](ms1) -- (cc);
\draw[arrow](cc) -- (ms2);
\draw[arrow](ms2) -- (detector);
\end{tikzpicture}
\end{center}
#+END_LaTeX



** Inlet table                                                     :noexport:
#+tblname: data-table
| Time | Flow |   %A |   %B |
|------+------+------+------|
|    0 | 0.65 | 99.5 |  0.5 |
| 14.0 | 0.65 | 70.0 | 30.0 |
| 17.5 | 0.65 | 70.0 | 30.0 |
| 18.5 | 0.65 | 99.5 |  0.5 |
| 19.5 | 0.65 | 99.5 |  0.5 |
| 24.0 |  0.7 | 99.5 |  0.5 |
| 25.0 | 0.65 | 99.8 |  0.5 |

** LC-MS/MS sample prep
- 10 \micro{}L of sample is mixed with 990 \micro{}L of IS in 0.5 mM Perfluoroheptanoic acid and centrifuge to deproteinize.
- 200 \micro{}L of supernatant is removed
- 7.5 \micro{}L is injected onto an octadecylsilyl (C18) stationary phase.


#+begin_src gnuplot :var data=data-table :file ./figures/outletmethod.png
set title "UPLC Gradient"
set xlabel "min"

set xrange [0:26]

set ylabel "percent"
set yrange [0:100]

plot data u 1:3 w lp lw 2 title 'A', \
     data u 1:4 w lp lw 2 title 'B'

#+end_src

#+ATTR_LATEX: :width 0.7\textwidth
#+RESULTS:
[[file:./figures/outletmethod.png]]


** Ion-Pairing Chromatography

#+BEGIN_LaTeX
\centering
\chemfig[][scale=.70]{CF_3-{(CF_2)_4}-CF_2-[::30](=[::60]O)-[::-60]OH}

\vspace{3em}

\ce{AA+ + PFHA-  <=> AA+ PFHA-}
#+END_LaTeX


** LC- MS/MS transitions
- ESI in positive mode
  - MRM

*** Quantified amino acids
\scriptsize
****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.3
:END:
- phosphoserine
- taurine
- phosphoethanolamine
- aspartate
- hydroxyproline
- threonine
- serine
- asparagine
- glutamate
- glutamine
- sarcosine
- aminoadipic
- proline
- glycine

****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.3
:END:


- alanine
- citulline
- 2-aminobutyric
- valine
- cystine
- saccharopine
- methionine
- alloisoleucine
- cystathionine
- isoleucine
- leucine
- arginosuccinic acid
- tyrosine
- \beta{}-alanine

****                                                               :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.3
:END:



- phenylalanine
- aminoisobutyric
- \gamma{}-aminobutryic
- ethanolamine
- hydroxylysine
- ornithine
- lysine
- 1-methylhistidine
- histidine
- tryptophan
- 3-methylhistidine
- anserine
- carnosine
- arginine
- s-sulfocyteine*




** Pros and Cons of LC-MS/MS
- As compared to FIA-MS/MS 
*** Pros
- 43 vs 11 amino acids quantified
  - Leu/Ile/Allo 
- Iso-baric compounds resolved
  - Leucine, Isoleucine, Alloisoleucine
*** Cons
- Too slow for NBS
- Manual peak integration


** Pros and Cons of LC-MS/MS
- As compared to AAA 
*** Pros
- ~ 30 min shorter analysis time
- Analyte specificity
  - Based on MRM rather than RT and ninhydrin reactivity
    - gentamycin, acetaminophen, dopamine analogs
  - Co-eluting substances cannot be separated and distinguished on a
    standard IEC chromatogram
    - Homocitrulline co-elutes with methionine
    - ASA co-elutes with leucine
    - Alloisoleucine co-elutes with cystathionine
    - Tryptophan co-elutes with histidine
- Long term reagent expense

*** Cons
- Upfront hardware expense
- Manual peak integration
- Lab developed test - not standardized
- Changing LOQ with equipment age 

